Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - MEDICINOVA INC | d10q.htm |
| EXCEL - IDEA: XBRL DOCUMENT - MEDICINOVA INC | Financial_Report.xls |
| EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - MEDICINOVA INC | dex312.htm |
| EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - MEDICINOVA INC | dex311.htm |
| EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - MEDICINOVA INC | dex321.htm |
| EX-10.44 - JOINT VENTURE AGREEMENT - MEDICINOVA INC | dex1044.htm |
EXHIBIT 32.2
CERTIFICATION OF
CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)
In connection with the accompanying Quarterly Report on Form 10-Q of MediciNova, Inc. (the “Company”) for the period ended June 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Coffee, as Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 15, 2011 | ||
| By: | /S/ MICHAEL COFFEE | |
| Michael Coffee Chief Business Officer and Interim Chief Financial Officer (Principal Financial Officer) | ||
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and such certification is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.